US FDA approves Vemurafenib , a Melanoma Drug
The United States Food and Drug Administration has approved vemurafenib (Zelboraf), a drug designed to treat patients with metastatic melanoma.
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine